FDA approves new Alzheimer’s treatment, donanemab from Eli Lilly
The Food and Drug Administration on Tuesday approved a new Alzheimer’s treatment called donanemab, paving the way for the third […]
The Food and Drug Administration on Tuesday approved a new Alzheimer’s treatment called donanemab, paving the way for the third […]